During the transformation of CD8+ T cells from effector T cells to memory T cells, activation of Sirt3, a mitochondrial deacetylase, reduces protein acetylation, which enhances OXPHOS activity and generation and survival of memory T cells, resulting in increased anti-tumor immune activity (23). Here, CD8A is linked to neoplasm.